학술논문
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial
Document Type
Article
Author
Source
In: Translational Cancer Research . (Translational Cancer Research, October 2023, 12(10):2959-2967)
Subject
Language
English
ISSN
22196803
2218676X
2218676X